Severe Raynaud's phenomenon—A streamlined approach to acute management  by Lee, Regent et al.
CS
R
D
a
A
R
R
A
A
K
R
I
E
1
r
(
s
o
o
a
a
p
t
b
b
a
v
c
2
p
c
g
ﬁ
l
d
2
dInternational Journal of Surgery Case Reports 2 (2011) 61–63
Contents lists available at ScienceDirect
International Journal of Surgery Case Reports
journa l homepage: www.e lsev ier .com/ locate / i j scr
ase report
evere Raynaud’s phenomenon—A streamlined approach to acute management
egent Lee ∗, Oliver Lomas, Ashok Handa
epartment of Vascular Surgery, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, United Kingdom
r t i c l e i n f o
rticle history:
eceived 10 January 2011
a b s t r a c t
Raynaud’s phenomenon is an exaggerated vasospastic response to cold or emotional stress which not
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the case of a 69-year-old woman who presented with rest pain, impending ulceration and necrosis of
ﬁnger tips due to an episode of left-sided Raynaud’s phenomenon. Intravenous prostacyclin was admin-
istered successfully as a bridge to endoscopic thoracic sympathectomy. Vascular surgery units are ideally
positioned for the acute management of severe Raynaud’s phenomenon to provide continuity of care to
patients with profound digital ischaemia and impending tissue loss.
n Coploprost
ndoscopic thoracic sympathectomy
Crow
. Introduction
Raynaud’s phenomenon (RP) is an exaggerated vasospastic
esponse to cold or to emotional stress that can be either primary
idiopathic) or secondary to a number of underlying conditions
uch as connective tissue disease, drugs or extrinsic vascular
bstruction. The phenomenon is characterised by the sudden onset
f cutaneous, acral vasospasmwhich results in cold extremities and
n associated sharp demarcation in colour of the skin that exhibits
delay in restitution upon re-warming.
During an attack of RP the patient may experience intense pain,
araesthesia and loss of manual dexterity. If the vasospasm is par-
icularly severe and long-lasting, the attack may be complicated
y critical ischaemia and necrosis of the digits. Restoration of acral
lood ﬂow is therefore an emergency that requires co-ordinated
nd timely management. The following report demonstrates how
ascular surgery is well placed as a specialty to manage Raynaud’s
rises acutely.
. Report
In June 2009, A 72-year old, right hand dominant, female patient
resented to the rheumatology clinic complaining of symptoms
onsistent with Raynaud’s phenomenon (RP) involving all the ﬁn-
ers of her left hand over the past 10 years. On examination the
ngers were blue at rest. Elevation of the hand produced pal-
or and on dependency, there was reactive hyperaemia of the
igits. Trophic changes of the ﬁngernails of the left side were
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evident and the left radial and ulnar pulses both palpable at the
wrist.
Extensive investigation by the rheumatologists revealed no
evidence of connective tissue disorder. Of the investigations for
an embolic source or anatomical anomalies, magnetic resonance
imaging revealed no evidence of a cervical rib or thoracic outlet
syndrome; duplex ultrasonography showed no arterial or venous
abnormality; and echocardiographic assessment demonstrated a
structurally normal heart. Medical therapy in the form of topical
nitrates, oral modiﬁed release nifedipine and oral sildenaﬁl were
initiated as ﬁrst line therapy but either not tolerated or ineffective.
A month after the initial presentation, she presented to the
emergency departmentwith severe rest pain and impending ulcer-
ation of the distal phalax of the little ﬁnger from a severe left-sided
Raynaud’s phenomenon (Fig. 1). The patient was treated with a
course of intravenous prostacyclin (Iloprost) over ﬁve consecutive
days with signiﬁcant improvement in her symptoms and no evi-
dence of further tissue loss (Fig. 2). On discharge from the hospital,
she was pain free and able to use her left hand for normal daily
activities.
At the same time, the patient enquired for a deﬁnitive proce-
dure for longer term symptomatic relief. The option of endoscopic
thoracic sympathectomy (ETS) was discussed and agreed upon.
The procedure was undertaken within a month of discharge from
the hospital with excellent immediate effect. The patient remained
pain-freewith no further exacerbations of RP in subsequent follow-
up visits.
Open access under CC BY-NC-ND license.3. Discussion
Raynaud’s phenomenon represents a failure of acral vasomotor
auto-regulation. To maintain adequate tissue perfusion, the bal-
-ND license.
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iFig. 1. Severe left sided Raynaud’s phenomenon.
nce of vasodilatation and vasoconstriction is tightly regulated by
ocal control mechanisms as well as neuro-hormonal mediators.
ncreased understanding of vascular biology and the pathophysiol-
gy of Raynaud’s has lead to a number of different pharmacolgical
nd surgical approaches tomanagement of the condition, including
ntravenous prostacyclin and ETS.
Prostaglandins are derivatives of arachidonic acid that possess
any systemic actions, including vasodilatation and inhibition of
latelet aggregation. Iloprost, synthetic prostaglandin I2 (PGI2),
as ﬁrst shown to be beneﬁcial for the alleviation of Ray-
aud’s phenomenon in the 1980s. Intravenous administration of
loprost, synthetic prostaglandin I2 (PGI2), is the ﬁrst line ther-
py for patients with acute exacerbations of digital ischaemia
nd impending ulceration. A multi-centre, randomised, parallel
lacebo-controlled, double-blind study of a 6h course of ilo-
rost repeated daily for ﬁve consecutive days showed signiﬁcant
mprovement in the condition including ulcer healing up to nine
eeks post infusion.1
Surgical intervention for Raynaud’s phenomenon is considered
hen medical therapy fails or is poorly tolerated, in this case with
opical nitrates andmodiﬁed release calciumchannel blockers. One
urgical option is ETS in which the sympathetic ganglia that supply
he affected limb are divided in order to diminish the vasoconstric-
ive sympathetic activity in the limb and hence shift the balance
f vascular tone away from constriction towards dilatation. Since
he ﬁrst large case series reported by Kux in 1951, ETS has been
sed effectively to treat several neurologic and vascular conditions,
ncluding Raynaud’s phenomenon.2
Fig. 2. Signiﬁcant improvement after lioprost infusion.gery Case Reports 2 (2011) 61–63
ETS is associated with fewer side-effects such as perma-
nent Horner’s syndrome and neuralgia compared to an open
approach and has gained acceptance as the preferred surgical tech-
nique for thoracodorsal sympathetomy. Though most case series
reported immediate improvement in symptoms and healing of
digital ulceration after ETS treatment for Raynaud’s phenomenon,
there remains controversy regarding the long-term efﬁcacy of
the procedure.2 A recent longitudinal follow-up study of patients
undergoing thoracoscopic sympathectomy found that one third of
patients had a long-lasting beneﬁt by 40 months of follow-up.3
Recurrence of symptoms after ETS treatment for Raynaud’s phe-
nomenon is likely to be multi-factorial and may not reﬂect failure
of the procedure. Maga et al. examined the microcirculatory status
in 25 patients who received ETS for Raynaud’s disease during the
5 years post procedure. Basal capillary ﬂow and maximal capillary
reﬁlling timeweremeasured using laser-doppler ﬂowmetry before
the ETS procedure and at every visit during the 5-year follow up
period. Signiﬁcant improvements in the microcirculatory function
to levels comparable to healthy volunteers were observed in these
patients immediately after the ETS procedure andweremaintained
at every visit during follow up. However, when assessed using
a subjective visual analogue scale, patients reported signiﬁcant
recurrence of symptoms as early as 6 months after the procedure
despite recovery of normal microcirculatory function evident by
the objective ﬂowmetry assessments.4
In the setting of severe RP with impending tissue loss, ETS is
uniquely placed to provide immediate term symptomatic relief and
additional long term success in the prevention ofmorbidity related
to digital ulceration. Matsumoto et al. reported a series of patients
whoundertookETSas treatment for severeRaynaud’sphenomenon
refractory to medical therapy. There was signiﬁcant symptomatic
relieve in the initial post-operative period, although patients did
report recurrence of symptoms in subsequent follow up. However,
there was no recurrence of digital ulceration from this cohort of
patients.5
4. Conclusion
This case highlights how a patient suffering from severe Ray-
naud’s phenomenon can be managed successfully by a vascular
surgery unit using iloprost infusion as a bridging therapy to
endoscopic thoracic sympathectomy. Although multi-disciplinary
evaluation of patient’s with RP is essential, vascular surgeons are
ideally placed to provide continuity of acute to long term care for
patients with severe digital ischaemia and impending tissue loss.
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